FDA Approval Summary: Trabectedin for Unresectable or Metastatic Liposarcoma or Leiomyosarcoma Following an Anthracycline-Containing Regimen

JOURNAL ARTICLE published 15 December 2017 in Clinical Cancer Research

Authors: Amy Barone | Dow-Chung Chi | Marc R. Theoret | Huanyu Chen | Kun He | Dubravka Kufrin | Whitney S. Helms | Sriram Subramaniam | Hong Zhao | Anuja Patel | Kirsten B. Goldberg | Patricia Keegan | Richard Pazdur